Catalyst Event
Sihuan Pharmaceutical Group Ltd (460) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/13/2026, 12:00:00 AM
The company repurchased 10 million of its own shares for approximately HK$10.93 million on May 13, 2026, as part of its ongoing buyback program. Importance is Low as routine share repurchases typically have a minor impact on share price; expected.
Korean Translation
2026년 5월 13일, 지속적인 자사주 매입 프로그램의 일환으로 약 1,093만 홍콩달러에 자사주 1,000만 주를 환매함. 자사주 매입 규모를 고려하여 'Low'로 추정함; 예상됨.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM